Abstract
There is high level evidence for the treatment of chronic lower limb radiculopathy with spinal cord stimulation (1). Although the rates of complications including lead migration and infection in SCS trials are well described in the literature (2), there are few published reports of new onset of severe pain caused by these trials and no reports of such pain being treated by re-programming of the device.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Neuromodulation: Technology at the Neural Interface
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
